ZIMLAB
Zim Laboratories Limited
If management delivers what it guided
arithmetic on filed guidance and past valuations · not a price target
ZIMLAB
FY26 → FY28 · 2 years of guidance · ~1.7 years from today₹113 today
BEAR
₹27
-76%-58% a yr
8.6% a year · 21x exit
BASE
₹47
-59%-41% a yr
14.8% a year · 32.4x exit
BULL
₹87
-23%-14% a yr
20.2% a year · 55.5x exit
Where the market has priced it
14x104x today — outside the range59x
- the guided figure reached earnings through a low-confidence bridge
- multiple band rests on only 4 filed years
- at 104x its FY26 earnings the stock already trades above the top of its own ten-year range (56x)
- the range is unusually wide — read it as the span of management's own claim, not as a forecast
How these numbers are produced
| Earnings base | FY26 fiscal year EPS ₹1.09 (screener) |
|---|---|
| Guided growth | 14.8% a year, said on the call of 23-May-2026 · transcript |
| Read across as | operating: unlabelled growth figure, read as revenue — low confidence |
| Delivery calibration | 0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings |
| Exit multiple | 21x / 32.39x / 55.51x, this company’s own p20 / median / p80 across 4 filed years |
| Arithmetic | base EPS × (1 + guided growth × delivery)2 × exit multiple |
Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.
What management said
from NSE earnings-call filings · extracted, not interpreted
ebitda margin 15%generic growth 15%
We are assuming, and we are projecting upper teens as our EBITDA margins once everything kind of starts going on in the regulated markets.
Call 23-May-2026 · bridge confidence low · transcript PDF